Form 8-K - Current report:
SEC Accession No. 0001564590-19-019255
Filing Date
2019-05-15
Accepted
2019-05-15 07:00:24
Documents
2
Period of Report
2019-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20190515.htm 8-K 29473
2 EX-99.1 stro-ex991_6.htm EX-99.1 140748
  Complete submission text file 0001564590-19-019255.txt   171423
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 19825018
SIC: 2836 Biological Products, (No Diagnostic Substances)